Ginkgo Bioworks Holdings (DNA) is set to release its quarterly earnings report on Tuesday, November 12th, 2024. Analysts expect a loss per share, and investors are hoping for signs of a turnaround after a year of declining share prices and financial challenges. This article provides a comprehensive analysis of Ginkgo Bioworks Holdings’ performance, including a look at key financial metrics and industry comparisons, to help investors understand what to expect from the upcoming earnings report.